EXAS - Exact Sciences Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
114.88
-2.02 (-1.73%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close116.90
Open117.00
Bid114.18 x 800
Ask114.88 x 1100
Day's Range114.28 - 117.76
52 Week Range47.78 - 121.98
Volume1,240,698
Avg. Volume1,537,653
Market Cap14.835B
Beta (3Y Monthly)2.36
PE Ratio (TTM)N/A
EPS (TTM)-1.77
Earnings DateJul 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est121.90
Trade prices are not sourced from all markets
  • Exact Sciences Designated a Great Place to Work-Certified™ Company in 2019
    PR Newswire5 days ago

    Exact Sciences Designated a Great Place to Work-Certified™ Company in 2019

    MADISON, Wis., July 17, 2019 /PRNewswire/ -- The more than 2,400 people of Exact Sciences work every day to create life-changing innovations in earlier cancer detection. Today, Exact Sciences announced that it is now Great Place to Work-Certified™. This certification is a significant achievement.

  • 10 Stocks to Sell for an Economic Slowdown
    InvestorPlace12 days ago

    10 Stocks to Sell for an Economic Slowdown

    Is the economy slowing down, or isn't it? Ask ten investors, and you'll get at least three different answers. One thing is for sure though -- the crowd won't come to a consensus on the matter until it's too late to do anything about it.Savvy investors know that planning ahead is a battle half-won. Decide now which names are exceedingly vulnerable to a market-wide pullback, and you're less likely to freeze up when the time comes to do so.Some of the following names move in the same direction as the overall market on any given day. The ones that are the most overextended, however, often end up being the ones that take the biggest bite out of a portfolio's value if and when things get hairy.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Retail Stocks to Buy for the Second Half of 2019 To that end, here's a look at ten stocks to sell should things take a decided turn for the worst. Advanced Micro Devices (AMD)Source: Shutterstock It's been one of the market's favorite stocks, if not the favorite, since its turnaround started to take hold in 2016, and was confirmed in 2018. But, graphics processing unit (GPU) and chip maker Advanced Micro Devices (NASDAQ:AMD) is highly vulnerable to a headwind, which in turns makes AMD stock highly vulnerable to profit-taking should investors start to sweat.Underscoring that vulnerability is a budding price war with rival Nvidia (NASDAQ:NVDA) at the end of a palpable refresh cycle. Just days before their launch earlier this month, Advanced Micro Devices cut the suggested price of its 5700 line of GPUs, countering Nvidia's recently-launched "Super" RTX graphics cards. Both product launches follow a string of new releases since early 2018, which may have already satisfied a market hungry for new GPUs.An economic slowdown could also easily curtail spending plans for big data centers, which have been big growth drivers for AMD as well as Nvidia. EXACT Sciences (EXAS)Source: Shutterstock EXACT Sciences (NASDAQ:EXAS) is a biopharma firm, and as such, isn't necessarily prone to economic weakness. Consumers don't skimp on healthcare when an insurer is paying the bills, even though they may skimp on other things.Nevertheless, after an almost 1500% rally from 2016's lows, EXACT Sciences stock is uncomfortably prone to a sizable pullback should the environment turn to malaise and doubt. * 10 Best Stocks for 2019: A Volatile First Half Though its top and bottom line are making tremendous forward progress thanks to solid demand for its Cologuard colon cancer screening test, the stock's got a valuation problem. As impressive as Cologuard is, trading at nearly 30 times revenue, the stock's current price is difficult to justify. Roku (ROKU)It's not a sweeping, decisive victory, and certainly not permanent, but Roku (NASDAQ:ROKU) so far has won the streaming set-top box wars. Now it's leading the SmartTV race with what should be 70% of that nascent market by year's end, according to Strategy Analytics.The refocus from hardware to selling ad space on its platform is also proceeding nicely.The triple-digit rally since the IPO in late 2017, however -- as well as the triple-digit rally since the end of last year -- is too much too fast. Driven more by hype than progress toward profits, even a small mood change could put the investors into profit-taking mode. Cyberark Software (CYBR)Cyberark Software (NASDAQ:CYBR) is in the cybersecurity business. Its 'Privileged' platform offers a unique solution that rivals like FireEye (NASDAQ:FEYE) or Palo Alto Networks (NYSE:PANW) can imitate, but not quite replicate. It's the company's Privileged suite, in fact, that was responsible for much of this year's heroic move.Last quarter's top line was up 34%, more than doubling the bottom line.Click to Enlarge * 7 A-Rated Stocks to Buy for the Rest of 2019 Investors are already having second thoughts about the move though, with a string of lower highs since the end of May alone. We have yet to see consistent lower lows, but if the support offered by the 100-day moving average line (gray) fails to keep shares propped up, a sizable setback could easily take shape. Zillow Group (ZG)Source: Shutterstock Though the economy has managed to continue growing despite stumbling blocks like steep tariffs and more migration of some jobs overseas, the housing market has already started to cool. In some regards it has even started to retreat.In March, prices of homes in the go-go real estate market of Southern California fell for the first time in seven years. They have since recovered, but even so, it's a microcosm of a bigger trend. Should the broad economy sour even more, an already-vulnerable housing market could entirely reverse course.That puts self-service real estate listing company Zillow Group (NASDAQ:ZG) in jeopardy. Shares are rallying right now, but it easily becomes one of the top stocks to sell once things merely start to get rocky. Verisign (VRSN)Source: Shutterstock Verisign (NASDAQ:VRSN) has been one of the most reliable advancers since the beginning of 2017, shrugging off the Q4-2018 market-wide weakness with relative ease, and renewing its march to higher highs. It has more than doubled in two years.What's amazing about the move is that it has taken shape on oddly anemic fiscal growth. Last year's top line was up just a little more than 4%, and this year's expectation is for barely more than 1%. Earnings growth is only marginally better. * 7 Retail Stocks to Buy That Are Down in 2019 Investors may be patient and lenient in a bullish environment like the one we've been in thus far. If those investors have to switch to a defensive mindset though, Verisign is exposed. Not only will the demand for website registration services wane, it will be tough to not notice there's no defensible moat in the business. Floor & Decor Holdings (FND)Source: Shutterstock Floor & Decor Holdings (NYSE:FND) isn't a household name, unless your house is near one of the 103 warehouse-format locales the company operates.That's the crux of the risk. While a strong economy inspires consumers to invest in their home's floors, flooring could easily be one of the planned expenses that gets put on hold when those consumers start to feel uneasy. The company also lacks the scale and diverse product lines that rivals Home Depot (NYSE:HD) and Lowe's (NYSE:LOW) enjoy, which shield them from economic headwinds. Snap (SNAP)Credit has to be given where it's due. Though it got off to a rocky start as a publicly-traded company, Snapchat parent Snap (NYSE:SNAP) eventually learned how to balance future growth with present results.It also learned the hard way that users of its social media platform are sensitive to sweeping changes. Rekindled user growth and revenue growth is a big part of the reason SNAP stock has managed to rally from under $5 late last year to its current price near $15. * 10 Stocks That Should Be Every Young Investor's First Choice With half the user base of Twitter (NYSE:TWTR) and less than one-tenth of the 2.4 billion regular users Facebook (NASDAQ:FB) boasts, should advertisers be forced to tighten their belts, a still-somewhat-unproven Snapchat would likely be the first advertising venue they'd drop. Vonage Holdings (VG)Source: Shutterstock Remember Vonage Holdings (NYSE:VG)? It was the first big name to capitalize on VOIP technologies, running a lengthy and aggressive ad campaign all throughout the early 2000's.The company never achieved the greatness that many anticipated. Rather than let a third-party utilize their internet service, ISPs simply added voice capabilities to their own menus. That, and mobile phones became the new norm.Vonage is still around though, finding its niche in the corporate world by facilitating all sorts if digital communications that can't be accomplished by mere phone connections. The stock's been a surprisingly strong performer, too.Still, with cheaper solutions constantly presenting themselves -- ranging from Skype to Twilio (NYSE:TWLO) to Dropbox (NASDAQ:DBX) -- Vonage's could be a relatively easy service to drop should cost-cutting become a priority. Wayfair (W)Finally, add Wayfair (NYSE:W) to your list of stocks to sell if and when the environment turns ugly.It's been an impressive performer to be sure. W stock is up more than 21% for the past year, and is higher to the tune of 99% for the past two years on expectations that it would be able to take at least a small bite out of the e-commerce dominance Amazon (NASDAQ:AMZN) enjoys. It's made headway to that end even.With actual profits still years down the road at the company's current trajectory, even the smallest of economic shakeups could force Wayfair to make a margin-pinching decision its bigger rival wouldn't be forced to make. More consumers can live without Wayfair than can live without Amazon.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about him at his website jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy on College Students' Radars * 7 Retail Stocks to Buy for the Second Half of 2019 * The S&P 500's 5 Best Highest-Yielding Dividend Stocks The post 10 Stocks to Sell for an Economic Slowdown appeared first on InvestorPlace.

  • Exact Sciences to host annual meeting, second-quarter 2019 results webcasts and calls
    PR Newswire13 days ago

    Exact Sciences to host annual meeting, second-quarter 2019 results webcasts and calls

    MADISON, Wis., July 9, 2019 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company will host webcasts and conference calls of its annual stockholders meeting and its second-quarter 2019 financial results. The company plans to release its second-quarter 2019 financial results after the close of the U.S. financial markets on July 30, 2019. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.

  • Why Exact Sciences Corporation Stock Gained Nearly 14% in June
    Motley Fool14 days ago

    Why Exact Sciences Corporation Stock Gained Nearly 14% in June

    The biotech's recent momentum is showing no signs of cooling off, despite its jaw-dropping valuation.

  • Exact Sciences Advances Fight Against Colorectal Cancer With Opening Of New Laboratory
    PR Newswire26 days ago

    Exact Sciences Advances Fight Against Colorectal Cancer With Opening Of New Laboratory

    MADISON, Wis., June 26, 2019 /PRNewswire/ -- Less than 20 months after breaking ground, Exact Sciences today opened the doors on its new, 169,000 square foot clinical laboratory and warehouse on the City of Madison's near west side. Exact Sciences is a biotechnology company focused on delivering life-changing innovations in earlier cancer detection. The laboratory opened Wednesday will process Cologuard, the company's colorectal cancer screening test.

  • What Kind Of Shareholders Own Exact Sciences Corporation (NASDAQ:EXAS)?
    Simply Wall St.27 days ago

    What Kind Of Shareholders Own Exact Sciences Corporation (NASDAQ:EXAS)?

    Every investor in Exact Sciences Corporation (NASDAQ:EXAS) should be aware of the most powerful shareholder groups...

  • Hedge Funds Have Never Been More Bullish On EXACT Sciences Corporation (EXAS)
    Insider Monkeylast month

    Hedge Funds Have Never Been More Bullish On EXACT Sciences Corporation (EXAS)

    Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards a company. This time it may be different. During the fourth quarter of 2018 we observed increased volatility and small-cap stocks underperformed the […]

  • Markitlast month

    See what the IHS Markit Score report has to say about Exact Sciences Corp.

    Exact Sciences Corp NASDAQ:EXASView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and increasing * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for EXAS with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on May 14. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold EXAS had net inflows of $1.92 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Benzinga2 months ago

    Jim Cramer Gives His Opinion On Wendy's, Exelon And More

    On CNBC's "Mad Money Lightning Round" , Jim Cramer said Wendys Co (NASDAQ: WEN ) is one of his absolute favorites. Cramer is a buyer of Zoetis Inc (NYSE: ZTS ). He added that the stock hit another ...

  • Exact Sciences to participate in June investor conferences
    PR Newswire2 months ago

    Exact Sciences to participate in June investor conferences

    MADISON, Wis., May 31, 2019 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that company management will be presenting at the following investor conferences and invited investors to participate by webcast. The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com. Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer.

  • The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer
    Zacks2 months ago

    The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer

    The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer

  • 3 Stocks to Win Big in the Fight Against Cancer
    Zacks2 months ago

    3 Stocks to Win Big in the Fight Against Cancer

    We highlight three stocks that are using innovative ways to treat cancer, also called malignancy. These stocks are also great long-term investments.

  • Exact Sciences Corporation (NASDAQ:EXAS): When Will It Breakeven?
    Simply Wall St.2 months ago

    Exact Sciences Corporation (NASDAQ:EXAS): When Will It Breakeven?

    Exact Sciences Corporation's (NASDAQ:EXAS): Exact Sciences Corporation, a molecular diagnostics company, focuses on...

  • Exact Sciences Advances Pipeline Capabilities with Mayo Clinic
    PR Newswire2 months ago

    Exact Sciences Advances Pipeline Capabilities with Mayo Clinic

    SAN DIEGO, May 20, 2019 /PRNewswire/ -- Early research using blood-based methylated DNA markers, identified through the longstanding collaboration between Exact Sciences and Mayo Clinic, demonstrates a potential to achieve 92% sensitivity and 92% specificity for detecting the most common type of pancreatic cancer. Researchers presented the findings at Digestive Disease Week (DDW) 2019, the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. "These pancreatic cancer data showcase the strength of our marker discovery collaboration with Mayo Clinic, a partnership that is fueling our product pipeline," said Kevin Conroy, chairman and CEO of Exact Sciences.

  • Exact Sciences Presents New Data Reinforcing Performance of Cologuard®
    PR Newswire2 months ago

    Exact Sciences Presents New Data Reinforcing Performance of Cologuard®

    SAN DIEGO, May 17, 2019 /PRNewswire/ -- New research from Exact Sciences and Mayo Clinic demonstrates the ability of Cologuard to both screen large patient populations and consistently help detect colorectal cancers and pre-cancers regardless of lesion location. The findings, presented at Digestive Disease Week (DDW) 2019, reinforce the role of Cologuard in improving colorectal cancer screening rates and patient outcomes. Despite recent efforts to positively impact colorectal cancer screening rates in the US, one-in-three Americans ages 50 to 75 are not up to date with recommended screening.i New research suggests the Cologuard test can help screen more people.

  • Exact Sciences returning $61K in WEDC tax credits because jobs were created outside Wisconsin: AP
    American City Business Journals2 months ago

    Exact Sciences returning $61K in WEDC tax credits because jobs were created outside Wisconsin: AP

    Exact Sciences Corp., the Madison-based maker of the Cologuard take-home colon cancer test and one of the largest public companies in Wisconsin, is reportedly returning $61,000 it received from the Wisconsin Economic Development Corp. because a certain number of jobs the money was intended for were created outside of Wisconsin. In 2015, Exact Sciences was approved by the WEDC to receive up to $9 million in tax credits if it added at least 750 jobs and made a capital investment of $26 million by 2020. Under the agreement, Exact Sciences would receive the WEDC tax incentives by investing in capital expenditures in Wisconsin and creating 758 new full-time positions – with an average wage of $24.47 per hour – in the state by Dec. 31, 2020.

  • 3 Top Healthcare Stocks to Buy in May
    Motley Fool2 months ago

    3 Top Healthcare Stocks to Buy in May

    These look like great picks to buy in May before you go away.

  • Guardant Health Takes Aim at Exact Sciences
    Motley Fool2 months ago

    Guardant Health Takes Aim at Exact Sciences

    A new study is planned that could someday reshape colon cancer screenings.

  • Why Exact Sciences Shrugged Off the Moody Market in April
    Motley Fool2 months ago

    Why Exact Sciences Shrugged Off the Moody Market in April

    Exact Sciences stock hit an all-time high last month, despite a sour market for biotech stocks.

  • The stock market’s reaction to this one word from the Fed’s Powell shows investors should be careful
    MarketWatch3 months ago

    The stock market’s reaction to this one word from the Fed’s Powell shows investors should be careful

    Sometimes the U.S. stock market sends a clear, unambiguous message. The message the stock market sent during Federal Reserve Chairman Jerome Powell’s press conference Wednesday says that the market is vulnerable. • The chart shows that the stock market rose immediately after the Fed decision was announced.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of EXAS earnings conference call or presentation 30-Apr-19 9:00pm GMT

    Q1 2019 Exact Sciences Corp Earnings Call

  • Exact Sciences Corp (EXAS) Q1 2019 Earnings Call Transcript
    Motley Fool3 months ago

    Exact Sciences Corp (EXAS) Q1 2019 Earnings Call Transcript

    EXAS earnings call for the period ending March 31, 2019.